Major depressive subtypes and treatment response

Biological Psychiatry

Volumn 42, Issue 7, 1997, Pages 568-576

  Fava, M ^a   Uebelacker, L A ^a   Alpert, J E ^a   Nierenberg, A A ^a   Pava, J A ^a   Rosenbaum, J F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Anxious depression; Atypical depression; Major depression; Melancholic depression; Subtypes

Indexed keywords

FLUOXETINE;

ADULT; ANXIETY NEUROSIS; ARTICLE; CLINICAL TRIAL; DEPRESSION; DISEASE CLASSIFICATION; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANCHOLIA; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY;

EID: 0030847475     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00440-4     Document Type: Article

References (45)

1. Abramson L Keshavan MS Sitaram N Elevated sleep and waking heart rates in anxious depressions Biol Psychiatry 26 1989 496 499
2. Alpert J Fava M Uebelacker L Nierenberg A Pava J Rosenbaum J Early-onset vs. late-onset major depressive disorder, Part 1: Axis 1 disorders 148th Annual Meeting of the American Psychiatric Association May 1995, Miami, Florida 1995
3. Clayton P Grove W Coryell W Keller M Hirschfeld R Fawcett J Follow-up and family study of anxious depression Am J Psychiatry 148 1991 1512 1517
4. Davidson J Miller R Strickland R Neuroticism and personality disorders in depression J Affect Disord 8 1985 177 182
5. Delini-Stula A Mikkelsen H Angst J Therapeutic efficacy of antidepressants in agitated anxious depression-A meta-analysis of moclobemide studies J Affect Disord 35 1995 21 30
6. Fava M Rosenbaum J McCarthy M Pava J Steingard R Bless E Anger attacks in depressed outpatients Psychopharmacol Bull 27 1991 275 279
7. Fava M Rosenbaum J Pava J McCarthy M Steingard R Bouffides E Anger attacks in unipolar depression: Part 1. Clinical correlates and response to fluoxetine treatment Am J Psychiatry 150 1993 1158 1163
8. Fava M Anderson K Rosenbaum JF Are thymolepticresponsive “anger attacks” a discrete clinical syndrome? Psychosomatics 34 1993 350 355
9. Fava M Bouffides E Pava JA McCarthy MK Steingard RJ Rosenbaum JF Personality disorder comorbidity with- major depression- and- response to- fluoxetine treatment Psychother Psychosom 62 1994 160 167
10. Fava M Rosenbaum JF McGrath PJ Stewart JW Amsterdam JD Quickin FM A double-blind, controlled study of lithium and tricyclic augmentation of fluoxetine in treatment resistant depression Am J Psychiatry 151 1994 1372 1374
11. Fava M Nierenberg AA Quitkin FM Zisook S Rosenbaum JF A preliminary study on the efficacy of sertraline and imipramine on anger attacks in depression NCDEU Annual Meeting Orlando, Florida 1995
12. Fava M Alpert JE Nierenberg AA Fluoxetine treatment of anger attacks: A replication study Ann Clin Psychiatry 8 1996 7 10
13. Fawcett J Kravitz H Anxiety syndromes and their relationship to depressive illness J Clin Psychiatry 44 1983 8 11
14. Gibbons R Clark D Kupfer D Exactly what does the Hamilton depression rating scale measure? J Psychiatr Res 27 1993 259 273
15. Gould KA Ball S Kaspi SP Prevalence and correlates of anger attacks: A two site study J Affect Disord 39 1996 31 38
16. Grunhaus L Harel Y Krugler T Pande A Haskett R Major depressive disorder and panic disorder: Effects of comorbidity on treatment outcome with antidepressant medications Clin Neuropharmacol 11 1988 454 461
17. Guelfi JD White C Hackett D Guichoux JY Magni G Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia J Clin Psychiatry 56 1995 450 458
18. rev. DHEW Pub. No. (ADM) 76-338 Guy W ECDEU Assessment Manual for Psychopharmacology 1976 NIMH Leiden
19. Hamilton M A rating scale for depression J Neurol Neurosurg Psychiatry 23 1960 56 62
20. Heiligenstein JH Tollefson GD Faries DE Response patterns of depressed outpatients with and without melancholia: A double-blind, placebo-controlled trial of fluoxetine vs. placebo J Affect Disord 30 1994 163 173
21. Hiller W Zaudig M Bose M The overlap between depression and anxiety on different levels of psychopathology J Affect Disord 16 1989 223 231
22. Joffe R Bagby M Levitt A Anxious and nonanxious depression Am J Psychiatry 150 1993 1257 1258
23. Keller M Shapiro R “Double depression”: Superimposition of acute depressive episodes on chronic depressive disorders Am J Psychiatry 139 1982 438 442
24. Keller M Lavori P Endicott J Coryell W Klerman G “Double depression”: Two year follow-up Am J Psychiatry 140 1983 689 694
25. Keller MB Harrison W Fawcett JA Treatment of chronic depression with sertraline or imipramine: Preliminary blinded response rates and high rates of undertreatment in the community Psychopharmacol Bull 31 1995 205 212
26. Lonngvist J Shivo S Syvalahti E Kiviruusu O Moclobemide and fluoxetine in atypical depression: A double-blind trial J Affect Disord 32 1994 169 177
27. Mammen O Shear K Greeno C Wheeler S Hughes C Anger attacks- and treatment nonadherence in pregnant and postpartum women NCDEU Annual Meeting Boca Raton, Florida 1996
28. Nelson JC Mazure CM Jatlow PI Characteristics of desipramine-refractory depression J Clin Psychiatry 55 1994 12 19
29. Overall JE The brief psychiatric rating scale in psychopharmacology research Pichot P Olivier-Martin R Psychological Measurement in Psychopharmacology: Modern Problems in Pharmacopsychiatry Vol. 7 1974 Karger Rockville, MD 66 78
30. Overall JE Hollister LE Johnson M Pennington V Nosology of depression and differential response to drugs JAMA 195 1966 162 164
31. Pande AC, Birkett M, Fechner-Bates S, Haskett RF, Greden JF (in press): Fluoxetine versus phenelzine in atypical depression. Biol Psychiatry.
32. Peselow ED Sanfilipo MP Difiglia C Fieve RR Melancholic/endogenous depression and response to somatic treatment and placebo Am J Psychiatry 149 1992 1324 1334
33. Quitkin FM Stewart JW McGrath PJ Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo Br J Psychiatry 163 suppl. 21 1993 30 34
34. Roose S Glassman R Walsh B Woodring S Tricyclic nonresponders: Phenomenology and treatment Am J Psychiatry 143 1986 345 348
35. Roose SP Glassman AH Attia E Woodring S Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia Am J Psychiatry 151 1994 1735 1739
36. Rosenbaum JR Fava M Nierenberg AA Sachs G Treatment resistant mood disorders Gabbard G Treatment of Psychiatric Disorders 2nd ed. 1995 American Psychiatric Association Basel 1275 1328
37. Rush AJ Weissenburger JE Melancholic symptom features and DSM-IV Am J Psychiatry 151 1994 489 498
38. Sato T Sakado K Sato S Morikawa T Cluster A personality disorder: A marker of worse treatment outcome of major depression? Psychiatry Res 53 1994 153 159
39. Shea M Widiger T Klein M Comorbidity of personality disorders and depression: Implications for treatment J Consult Clin Psychol 60 1992 857 868
40. Sotsky SM Glass DR Shea T Patient predictors of and Schizophrenia (SADS) 3rd ed 1991 New York State Psychiatric Institute, Biometrics Research Washington, DC
41. Spitzer RL Williams JB Structured Clinical Interview for DSM-III-R (SCID) 1987 Biometrics Research Department, New York State Psychiatric Institute New York
42. (SCID-II, 9/1/89 version) Spitzer R Williams J Gibbon M First M Structured Clinical Interview for DSM-III-R Personality Disorders 1989 Biometrics Research Department, New York State Psychiatric Institute New York
43. (SCID=P; 9/l/89 Version) Spitzer RL Williams JBW Gibbon M First MB Structured Clinical Interview for DSM-III-R-Patient Edition 1989 Biometrics Research Department, New York State Psychiatric Institute New York
44. Stewart J McGrath P Quitkin F Can mildly depressed patients with atypical depression benefit from antidepressants? Am J Psychiatry 149 1992 615 619
45. Sullivan PF Joyce PR Mulder RT Borderline personality disorder in major depression J Nerv Ment Dis 182 1994 508